Citadel Advisors - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is and the CUSIP is 37890U908. A total of 3 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2016$328,00019,8000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2016
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,312$4,986,0000.64%
BOOTHBAY FUND MANAGEMENT, LLC 228$866,0000.09%
GROUP ONE TRADING, L.P. 124,400$4,727,0000.04%
SIMPLEX TRADING, LLC 421$1,599,0000.01%
JPMORGAN CHASE & CO 149,900$5,696,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders